Literature DB >> 15785814

Synthesis of 5'-methylenearisteromycin and its 2-fluoro derivative with potent antimalarial activity due to inhibition of the parasite S-adenosylhomocysteine hydrolase.

Chieko Takagi1, Makoto Sukeda, Hye-Sook Kim, Yusuke Wataya, Saori Yabe, Yukio Kitade, Akira Matsuda, Satoshi Shuto.   

Abstract

5'-methylenearisteromycin 5 and its 2-fluoro derivative 6, which were designed as antimalarial agents because of their AdoHcy hydrolase inhibition, were synthesized from D-ribose, using a stereoselective intramolecular radical cyclization as the key step to construct the carbocyclic structure. These compounds were evaluated as AdoHcy hydrolase inhibitors with the recombinant human and malarial parasite enzymes. Although 5 and 6 were both potent inhibitors of the malarial parasite AdoHcy hydrolase, the 2-fluoro derivative 6 proved to be superior due to its lower inhibitory effect on the human enzyme. In addition, 6 was identified as a potent antimalarial agent using an in vitro assay system with Plasmodium falciparum.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15785814     DOI: 10.1039/b418829b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Diastereoselective Synthesis of 6″-(Z)- and 6″-(E)-Fluoro Analogues of Anti-hepatitis B Virus Agent Entecavir and Its Evaluation of the Activity and Toxicity Profile of the Diastereomers.

Authors:  Hiroki Kumamoto; Misato Fukano; Tomohiko Nakano; Keito Iwagami; Chiaki Takeyama; Satoru Kohgo; Shuhei Imoto; Masayuki Amano; Nobuyo Kuwata-Higashi; Manabu Aoki; Hiroshi Abe; Hiroaki Mitsuya; Kiyoshi Fukuhara; Kazuhiro Haraguchi
Journal:  J Org Chem       Date:  2016-03-24       Impact factor: 4.354

2.  Synthesis and antiplasmodial activity of purine-based C-nucleoside analogues.

Authors:  Kartikey Singh; Prince Joshi; Rohit Mahar; Pragati Baranwal; Sanjeev K Shukla; Renu Tripathi; Rama Pati Tripathi
Journal:  Medchemcomm       Date:  2018-05-29       Impact factor: 3.597

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.